Reply #25: It's Relenza that works. The license is owned by Glaxo Smith Wellcome.

[PVK]

It is manufactured by Biota in Australia.

Also, notice that Biota sued Glaxo last May over lost Relenza sales/profits after two years of discussions failed. Think someone is trying to deep-six Relenza in favor of Tamiflu???

http://www.theage.com.au/articles/2004/05/05/1083635204662.html?from=storyrhs

{snip}

On its launch in 1999, he said Relenza had captured 48 per cent of the emerging market for broad-spectrum flu drugs but sales had plummeted to just 3 per cent after the newly merged GSK withdrew marketing and support for the product.

"Biota is seeking recovery of lost royalties for the past five years and lost royalties over the next up to 10 years for the life of Relenza's patents . . . There is no reason why Relenza couldn't have been a $500 million drug," Mr Molloy said.

{snip}

It is expected to take a year to 18 months for the case to go to trial. A directions hearing is scheduled for June 18.

Biota is seeking recovery of lost royalties for the past five years and up to the next 10 years.
PETER MOLLOY, Biota CEOMr Molloy said Biota's share price at the time that Relenza was launched gave the company a market capitalisation of up to $500 million and today it was about $70 million.

Professor Sir Gustav Nossal, one of Australia's leading medical biologists and former director of the Walter and Eliza Hall Institute of Medical Research, yesterday said Relenza was "one of the greatest Australian research inventions of all time. It is a major Australian tragedy that this drug is not being used much more widely."